HYDRA BIOSCIENCES
Hydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise in novel ion channels. Hydra's proprietary high throughput screening platforms enable the company to identify and develop drug candidates that address significant unmet medical needs. Hydra's ion channel drug discovery program is currently focused on channels implicated in pain, inflammation, and cardiovascula... r disease. Hydra's intellectual property portfolio, significant ion channel expertise, and flexible screening systems set it apart from other biopharmaceutical companies. Unlike classical sodium, calcium, or potassium voltage-gated channels Hydra's novel ion channels provide the potential to develop selective and safer ion channel drugs. Hydra has raised significant financing from blue-chip investors since its inception. This prominent group of investors includes Abingworth Ventures, Advanced Technology Ventures, Polaris Ventures, Lilly Bio Ventures, New Enterprise Associates, BioVentures Investors, Biogen Idec, Boston Medical Investors, and MedImmune Ventures.
HYDRA BIOSCIENCES
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.hydrabiosciences.com
Total Employee:
11+
Status:
Active
Contact:
617-494-5230
Email Addresses:
[email protected]
Total Funding:
94.88 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Microsoft Microsoft Azure Network Solutions DNS Confluence Networks Microsoft Azure US North Region
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Advanced Technology Ventures
Advanced Technology Ventures investment in Series D - Hydra Biosciences
Biogen Idec
Biogen Idec investment in Series D - Hydra Biosciences
Polaris Partners
Polaris Partners investment in Series D - Hydra Biosciences
Abingworth
Abingworth investment in Series D - Hydra Biosciences
MedImmune Ventures
MedImmune Ventures investment in Series D - Hydra Biosciences
Bioventures Investors
Bioventures Investors investment in Series D - Hydra Biosciences
Lilly Ventures
Lilly Ventures investment in Series D - Hydra Biosciences
Lilly Ventures
Lilly Ventures investment in Series C - Hydra Biosciences
Advanced Technology Ventures
Advanced Technology Ventures investment in Series C - Hydra Biosciences
Polaris Partners
Polaris Partners investment in Series C - Hydra Biosciences
Official Site Inspections
http://www.hydrabiosciences.com
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hydra Biosciences"
Hydra Biosciences - Crunchbase Company Profile
Organization. Hydra Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Hydra Biosciences - LinkedIn
Hydra Biosciences is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that develops drugs to treat pain, inflammation, renal disease, anxiety and ...See details»
Hydra Biosciences 2025 Company Profile: Valuation, …
Hydra Biosciences General Information Description. Developer of molecular regeneration medicines intended to treat pain, inflammation, anxiety and other diseases. The company's medicines focuses in the field of Transient Receptor …See details»
Hydra Biosciences - 2025 Company Profile - Tracxn
Hydra Biosciences is a series E company based in Cambridge (United States), founded in 2001. It operates as a Develops ion-channel based drugs for diabetic neuropathy, allergic asthma and …See details»
Hydra Biosciences, Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hydra Biosciences, Inc of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Hydra Biosciences Inc. - life-sciences-usa.com
Sep 21, 2004 Hydra Biosciences Inc. https://www.hydrabiosciences.com Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops …See details»
Hydra Biosciences: Revenue, Worth, Valuation & Competitors 2024
About Hydra Biosciences. Hydra Biosciences is a Biotech related company founded in 2001 and based in Cambridge with 10 employees an estimated revenue of $1.6M, and. It has 10 …See details»
Hydra Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Hydra Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 6 literature, Disease Domain:Nervous System Diseases, Technology …See details»
Hydra Biosciences Inc - Company Profile and News
Hydra Biosciences, Inc. operates as a biopharmaceutical company. The Company develops novel drugs to treat pain, renal, inflammation, pulmonary, anxiety, and other diseases. Hydra …See details»
Hydra Biosciences, Inc. - VentureRadar
" Hydra Biosciences is using its expertise in the recently discovered Transient Receptor Potential (TRP) family of ion channels, together with a proprietary screening platform for these …See details»
Hydra Biosciences - Crustdata Company Profile, Funding and Growth
Hydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its …See details»
Hydra Biosciences - Products, Competitors, Financials, Employees ...
Hydra Biosciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13112018 Prices from USD $250. Dec 26, 2018. 21:40 EST 25 Dec 2018 | BioPortfolio …See details»
Hydra Biosciences - EquityNet
Hydra Biosciences, a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise …See details»
Hydra Biosciences Inc. - BioCentury Company Profiles - BCIQ
Oct 2, 2020 Hydra Biosciences Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Hydra Biosciences - Overview, News & Similar companies
Hydra Biosciences Inc is a company that operates in the Biotechnology industry. It employs 11-20 people and has $1M-$5M of revenue. Is this data correct? Popular Searches Hydra …See details»
Hydra Biosciences - CB Insights
He also founded Boston Medical Investors in 1994 and currently serves as a Director of Good Start Genetics, Olaris Therapeutics, Immuneering Inc, Hydra Biosciences, and Lysosomal …See details»
Hydra Biosciences Company Overview, Contact Details
Collaboration with Eli Lilly Hydra Biosciences has partnered with Eli Lilly to develop drugs targeting chronic pain syndromes, presenting a sales opportunity to leverage this collaboration …See details»
Emerging Drug Developer: Hydra Biosciences | Fierce Biotech
Hydra Biosciences stakes its future on ion channels When Hydra Biosciences announced last week that it had raised $22 million in its Series D round, the developer earmarked much of that …See details»
Hydra Biosciences: Chemistry & Biology - Cell Press
Although Hydra Biosciences is in the business of finding new ways to repair and regenerate injured heart cell tissues, they are not a cell-based therapy company. This means no stem …See details»
Hydra Biosciences, Inc. Receives Approval From Health Canada
Apr 14, 2015 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Hydra Biosciences, a leader in the field of Transient Receptor Potential (TRP) channel modulation, today announced that Health …See details»